Clinical trial
Association Between Hypertension, Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19
NCT04374695 is registered in ClinicalTrials.gov with Versailles Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Association Between Hypertension, Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19
- Lead sponsor
- Versailles Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2020
- Completion date
- July 1, 2020
- Enrollment
- 700 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.